Lumida
/ECBK
⌘K
ECB Bancorp Inc

ECB Bancorp Inc

ECBK
$21.21USD↑+1.87%+0.39 today

MARKET CAP

185.3M

P/E (TTM)

22.6x

FWD P/E

—

DAY RANGE

$20 – $21

52W RANGE

$15
$22

AI Summary

Stalk
Buy NowMedium

ECBK remains in a Stage 2 advancing uptrend with rising EMAs and volume confirming higher highs, and despite extreme overbought readings, the active Lockout Rally dynamics support further upside; initiate Buy Now to capture continuation momentum, using shallow pullbacks into the 9/21 EMAs as participation zones. Primary risk is a single‐bar exhaustion signal and failure to hold above the EMAs.

  • ↑Q2 net income rose to $3.26M vs $1.44M YoY; EPS $0.39.
  • ↑Total risk-based capital ratio 14.9% and CET1 ratio 13.94% exceed well-capitalized benchmarks.
  • ↓Average analyst target ~$10 implies 51% decline from current $20.55.
Full analysis →

Buying

4

institutions

Selling

1

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY418.39 K8.40 M+23.74 K+27.2%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL83.80 K1.68 M+-4.07 K+14.5%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW13.76 K276.22 K+13.76 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW10.08 K202.47 K+10.08 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY3.11 K62.47 K+31.00+22.6%0.00%